Acenxion Biosytems, Inc.

New Filing
CIK: 0001974107·Biotechnology·DELAWARE·Filed: Apr 18, 2023
Total Offering

$2,000,023

Amount Sold

$50,000

Investors

1

First Sale

Apr 1, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Roy Swiger
Related Person
Brian Struchtemeyer
Related Person
Wayne Carter
Related Person
Howard Goldstein
Related Person

Company

Acenxion Biosytems, Inc.

2002 W. 39TH AVE

KANSAS CITY, KS, 66103

3217490523

SEC Filing

0001974107-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Acenxion Biosytems, Inc. Form D Filing — $2,000,023 | FilingFlow